1. Wu, Shufei, Liu, Mengying, Zhang, Mingrui, Huang, Xinmei, Cao, Mengshu. 2024. The gene expression of CALD1, CDH2, and POSTN in fibroblast are related to idiopathic pulmonary fibrosis. In Frontiers in immunology, 15, 1275064. doi:10.3389/fimmu.2024.1275064. https://pubmed.ncbi.nlm.nih.gov/38370408/
2. Du, YiHeng, Jiang, Xiang, Wang, Bo, Wang, XiZhi, Liu, HaiTao. 2021. The cancer-associated fibroblasts related gene CALD1 is a prognostic biomarker and correlated with immune infiltration in bladder cancer. In Cancer cell international, 21, 283. doi:10.1186/s12935-021-01896-x. https://pubmed.ncbi.nlm.nih.gov/34051818/
3. Zhang, Sheng, Wang, Qin, Li, Wenfeng, Chen, Jinzhong. 2022. MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing. In Frontiers in molecular biosciences, 8, 793493. doi:10.3389/fmolb.2021.793493. https://pubmed.ncbi.nlm.nih.gov/35127818/
4. Zheng, Hang, Bai, Yuge, Wang, Jingui, Liu, Yucun, Wang, Xin. 2021. Weighted Gene Co-expression Network Analysis Identifies CALD1 as a Biomarker Related to M2 Macrophages Infiltration in Stage III and IV Mismatch Repair-Proficient Colorectal Carcinoma. In Frontiers in molecular biosciences, 8, 649363. doi:10.3389/fmolb.2021.649363. https://pubmed.ncbi.nlm.nih.gov/33996905/
5. Meng, Zhishang, Chen, Yanzhu, Wu, Wenyi, Yao, Xiaoxi, Luo, Jing. 2022. Exploring the Immune Infiltration Landscape and M2 Macrophage-Related Biomarkers of Proliferative Diabetic Retinopathy. In Frontiers in endocrinology, 13, 841813. doi:10.3389/fendo.2022.841813. https://pubmed.ncbi.nlm.nih.gov/35692390/
6. Liu, Yixuan, Xie, Suhong, Zhu, Keyu, Guo, Lin, Lu, Renquan. 2021. CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers. In Heliyon, 7, e07257. doi:10.1016/j.heliyon.2021.e07257. https://pubmed.ncbi.nlm.nih.gov/34189308/
7. Li, Wei, Huang, Limei, Qi, Nana, Zhang, Qinle, Qin, Zailong. 2024. Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target. In BMC genomics, 25, 183. doi:10.1186/s12864-024-10056-0. https://pubmed.ncbi.nlm.nih.gov/38365611/
8. Ma, Wen-Qian, Miao, Ming-Chang, Ding, Ping-An, Zhang, Zhi-Dong, Zhao, Qun. . CALD1 facilitates epithelial-mesenchymal transition progression in gastric cancer cells by modulating the PI3K-Akt pathway. In World journal of gastrointestinal oncology, 16, 1029-1045. doi:10.4251/wjgo.v16.i3.1029. https://pubmed.ncbi.nlm.nih.gov/38577446/
9. Li, Cheng, Yang, Fuhan, Wang, Ruiliang, Wang, Hong, Yao, Xudong. . CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway. In Annals of translational medicine, 9, 1441. doi:10.21037/atm-21-4192. https://pubmed.ncbi.nlm.nih.gov/34733993/